Prodromal dementia with Lewy bodies

Psychological Medicine

Volumn 45, Issue 2, 2015, Pages 259-268

  Donaghy, P C ^a   O'Brien, J T ^b   Thomas, A J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Dementia with Lewy bodies; mild cognitive impairment; prodromal; REM sleep behaviour disorder

Indexed keywords

BIOLOGICAL MARKER;

DISEASE COURSE; HUMAN; LEWY BODY DISEASE; MILD COGNITIVE IMPAIRMENT; PRODROMAL SYMPTOM; REM SLEEP BEHAVIOR DISORDER; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

BIOMARKERS; DISEASE PROGRESSION; HUMANS; LEWY BODY DISEASE; MILD COGNITIVE IMPAIRMENT; PRODROMAL SYMPTOMS; REM SLEEP BEHAVIOR DISORDER; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84927693500     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291714000816     Document Type: Review

References (49)

1. Aisen PS, Vellas B, Hampel H (2013). Moving towards early clinical trials for amyloid-targeted therapy in Alzheimers disease. Nature Reviews. Drug Discovery 12, 324
2. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, SnyDer PJ, Carrillo MC, Thies B, Phelps CH (2011). The diagnosis of mild cognitive impairment due to Alzheimers disease: recommendations from the National Institute on Aging-Alzheimers Association workgroups on diagnostic guiDelines for Alzheimers disease. Alzheimers and Dementia 7, 270-279
3. Albin R, Koeppe R (2006). Rapid loss of striatal VMAT2 binding associated with onset of Lewy body Dementia. Movement DisorDers 21, 287-288
4. Albin RL, Burke JF, Koeppe RA, Giordani B, Gilman S, Frey KA (2013). Assessing mild cognitive impairment with amyloid and dopamine terminal molecular imaging. Journal of Nuclear Medicine 54, 887-893
5. Auning E, Rongve A, Fladby T, Booij J, Hortobagyi T, Siepel FJ, Ballard C, Aarsland D (2011). Early and presenting symptoms of Dementia with Lewy bodies. Dementia and Geriatric Cognitive DisorDers 32, 202-208
6. Ballard C, Grace J, McKeith I, Holmes C (1998). Neuroleptic sensitivity in Dementia with Lewy bodies and Alzheimers disease. Lancet 351, 1032-1033
7. Boeve BF, Silber MH, Ferman TJ, Kokmen E, Smith GE, Ivnik RJ, Parisi JE, Olson EJ, Petersen RC (1998). REM sleep behavior disorDer and Degenerative Dementia: an association likely reflecting Lewy body disease. Neurology 51, 363-370
8. Boeve BF, Silber MH, Parisi JE, Dickson DW, Ferman TJ, Benarroch EE, Schmeichel AM, Smith GE, Petersen RC, Ahlskog JE, Matsumoto JY, Knopman DS, Schenck CH, Mahowald MW (2003). Synucleinopathy pathology and REM sleep behavior disorDer plus Dementia or parkinsonism. Neurology 61, 40-45
9. Bombois S, Debette S, BruanDet A, Delbeuck X, Delmaire C, Leys D, Pasquier F (2008). Vascular subcortical hyperintensities predict conversion to vascular and mixed Dementia in MCI patients. Stroke 39, 2046-2051
10. Chiba Y, Fujishiro H, Iseki E, Ota K, Kasanuki K, Hirayasu Y, Satoa K (2012). Retrospective survey of prodromal symptoms in Dementia with Lewy bodies: comparison with Alzheimers disease. Dementia and Geriatric Cognitive DisorDers 33, 273-281
11. Claassen DO, Josephs KA, Ahlskog JE, Silber MH, Tippmann-Peikert M, Boeve BF (2010). REM sleep behavior disorDer preceding other aspects of synucleinopathies by up to half a century. Neurology 75, 494-499
12. Clerici F, Del Sole A, Chiti A, Maggiore L, Lecchi M, Pomati S, Mosconi L, Lucignani G, Mariani C (2009). Differences in hippocampal metabolism between amnestic and non-Amnestic MCI subjects: automated FDG-PET image analysis. Quarterly Journal of Nuclear Medicine and Molecular Imaging 53, 646-657
13. Dang-Vu TT, Gagnon JF, VenDette M, Soucy JP, Postuma RB, Montplaisir J (2012). Hippocampal perfusion predicts impending neuroDegeneration in REM sleep behavior disorDer. Neurology 79, 2302-2306
14. Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, OBrien J, Pasquier F, Robert P, Rossor M, Salloway S, Sarazin M, De Souza LC, Stern Y, Visser PJ, Scheltens P (2010). Revising the Definition of Alzheimers disease: a new lexicon. Lancet Neurology 9, 1118-1127
15. Dugger BN, Boeve BF, Murray ME, Parisi JE, Fujishiro H, DicksonDW, Ferman TJ (2012). Rapid eye movement sleep behavior disorDer and subtypes in autopsy-confirmed Dementia with Lewy bodies. Movement DisorDers 27, 72-78
16. Fayed N, Davila J, Oliveros A, Castillo J, Medrano JJ (2008). Utility of different MR modalities in mild cognitive impairment and its use as a predictor of conversion to probable Dementia. AcaDemic Radiology 15, 1089-1098
17. Ferman TJ, Boeve BF, Smith GE, Lin SC, Silber MH, Pedraza O, Wszolek Z, Graff-Radford NR, Uitti R, Van Gerpen J, Pao W, Knopman D, Pankratz VS, Kantarci K, Boot B, Parisi JE, Dugger BN, Fujishiro H, Petersen RC, Dickson DW (2011). Inclusion of RBD improves the diagnostic classification of Dementia with Lewy bodies. Neurology 77, 875-882
18. Fischer P, Jungwirth S, Zehetmayer S, Weissgram S, Hoenigschnabl S, Gelpi E, Krampla W, Tragl KH (2007). Conversion from subtypes of mild cognitive impairment to Alzheimer Dementia. Neurology 68, 288-291
19. Fujishiro H, Ferman TJ, Boeve BF, Smith GE, Graff-Radford NR, Uitti RJ, Wszolek ZK, Knopman DS, Petersen RC, Parisi JE, Dickson DW (2008). Validation of the neuropathologic criteria of the third consortium for Dementia with Lewy bodies for prospectively diagnosed cases. Journal of Neuropathology and Experimental Neurology 67, 649-656
20. Fujishiro H, Iseki E, Nakamura S, Kasanuki K, Chiba Y, Ota K, Murayama N, Sato K (2013). Dementia with Lewy bodies: early diagnostic challenges. Psychogeriatrics 13, 128-138
21. Gaenslen A, Swid I, Liepelt-Scarfone I, Godau J, Berg D (2011). The patients perception of prodromal symptoms before the initial diagnosis of Parkinsons disease. Movement DisorDers 26, 653-658
22. Harvey RJ, Skelton-Robinson M, Rossor MN (2003). The prevalence and causes of Dementia in people unDer the age of 65 years. Journal of Neurology, Neurosurgery, and Psychiatry 74, 1206-1209
23. Iranzo A, Lomena F, Stockner H, VallDeoriola F, Vilaseca I, Salamero M, Molinuevo JL, SerraDell M, Duch J, Pavia J, Gallego J, Seppi K, Hogl B, Tolosa E, Poewe W, Santamaria J (2010). Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorDer: a prospective study [corrected]. Lancet Neurology 9, 1070-1077
24. Iranzo A, Tolosa E, Gelpi E, Molinuevo JL, VallDeoriola F, SerraDell M, Sanchez-Valle R, Vilaseca I, Lomena F, Vilas D, Llado A, Gaig C, Santamaria J (2013). NeuroDegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorDer: an observational cohort study. Lancet Neurology 12, 443-453
25. Jicha GA, Schmitt FA, Abner E, Nelson PT, Cooper GE, Smith CD, Markesbery WR (2010). Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease. Neurobiology of Aging 31, 1805-1813
26. McKeith IG, Dickson DW, Lowe J, Emre M, OBrien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, LitVan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M (2005). Diagnosis and management of Dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65, 1863-1872
27. Molano J, Boeve B, Ferman T, Smith G, Parisi J, Dickson D, Knopman D, Graff-Radford N, Geda Y, Lucas J, Kantarci K, Shiung M, Jack C, Silber M, Pankratz VS, Petersen R (2010). Mild cognitive impairment associated with limbic and neocortical Lewy body disease: a clinicopathological study. Brain 133, 540-556
28. Palmqvist S, Hertze J, Minthon L, Wattmo C, Zetterberg H, Blennow K, Londos E, Hansson O (2012). Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimers disease in mild cognitive impairment: six-year follow-up study. PLoS One 7, e38639
29. Pardo JV, Lee JT, Kuskowski MA, Munch KR, Carlis JV, Sheikh SA, Surerus C, Lewis SM, McCarten JR, Fink H, McPherson S, Shah HH, Rottunda S, Dysken MW (2010). FluoroDeoxyglucose positron emission tomography of mild cognitive impairment with clinical follow-up at 3 years. Alzheimers and Dementia 6, 326-333
30. Paulsen JS, Langbehn DR, Stout JC, Aylward E, Ross CA, Nance M, Guttman M, Johnson S, MacDonald M, Beglinger LJ, Duff K, Kayson E, Biglan K, Shoulson I, Oakes D, HayDen M (2008). Detection of Huntingtons disease DecaDes before diagnosis: the Predict-HD study. Journal of Neurology, Neurosurgery, and Psychiatry 79, 874-880
31. Petersen RC (2004). Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine 256, 183-194
32. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B (2001). Current concepts in mild cognitive impairment. Archives of Neurology 58, 1985-1992
33. Petersen RC, Parisi JE, Dickson DW, Johnson KA, Knopman DS, Boeve BF, Jicha GA, Ivnik RJ, Smith GE, Tangalos EG, Braak H, Kokmen E (2006). Neuropathologic features of amnestic mild cognitive impairment. Archives of Neurology 63, 665-672
34. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999). Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology 56, 303-308
35. Postuma RB, Gagnon JF, Pelletier A, Montplaisir J (2013). Prodromal autonomic symptoms and signs in Parkinsons disease and Dementia with Lewy bodies. Movement DisorDers 28, 597-604
36. Postuma RB, Gagnon JF, VenDette M, Desjardins C, Montplaisir JY (2011). Olfaction and color vision iDentify impending neuroDegeneration in rapid eye movement sleep behavior disorDer. Annals of Neurology 69, 811-818
37. Postuma RB, Gagnon JF, VenDette M, Fantini ML, Massicotte-Marquez J, Montplaisir J (2009). Quantifying the risk of neuroDegenerative disease in idiopathic REM sleep behavior disorDer. Neurology 72, 1296-1300
38. Postuma RB, Lanfranchi PA, Blais H, Gagnon JF, Montplaisir JY (2010). Cardiac autonomic dysfunction in idiopathic REM sleep behavior disorDer. Movement DisorDers 25, 2304-2310
39. Postuma RB, Lang AE, Gagnon JF, Pelletier A, Montplaisir JY (2012). How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorDer. Brain 135, 1860-1870
40. Saito Y, Murayama S (2007). Neuropathology of mild cognitive impairment. Neuropathology 27, 578-584
41. Schenck CH, Boeve BF, Mahowald MW (2013). Delayed emergence of a parkinsonian disorDer or Dementia in 81% of olDer males initially diagnosed with idiopathic REM sleep behavior disorDer (RBD): a 16-year update on a previously reported series. Sleep Medicine 14, 744-748
42. SchneiDer JA, ArVanitakis Z, Leurgans SE, Bennett DA (2009). The neuropathology of probable Alzheimer disease and mild cognitive impairment. Annals of Neurology 66, 200-208
43. Siepel FJ, Rongve A, Buter TC, Beyer MK, Ballard CG, Booij J, Aarsland D (2013). (123I)FP-CIT SPECT in suspected Dementia with Lewy bodies: a longitudinal case study. British Medical Journal Open 3, e002642
44. Tabrizi SJ, Reilmann R, Roos RA, Durr A, Leavitt B, Owen G, Jones R, Johnson H, Craufurd D, Hicks SL, Kennard C, Landwehrmeyer B, Stout JC, Borowsky B, Scahill RI, Frost C, Langbehn DR (2012). Potential endpoints for clinical trials in premanifest and early Huntingtons disease in the TRACK-HD study: analysis of 24 month observational data. Lancet Neurology 11, 42-53
45. Tiraboschi P, Hansen LA, Alford M, MerDes A, Masliah E, Thal LJ, Corey-Bloom J (2002). Early and wiDespread cholinergic losses differentiate Dementia with Lewy bodies from Alzheimer disease. Archives of General Psychiatry 59, 946-951
46. Troster AI (2008). Neuropsychological characteristics of Dementia with Lewy bodies and Parkinsons disease with Dementia: differentiation, early Detection, and implications for mild cognitive impairment and biomarkers. Neuropsychology Review 18, 103-119
47. Vann Jones SA, OBrien JT (2014). The prevalence and inciDence of Dementia with Lewy bodies: a systematic review of population and clinical studies. Psychological Medicine 44, 673-683
48. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Backman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, De Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, Van Duijn C, Visser P, Petersen RC (2004). Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine 256, 240-246
49. Yoshizawa H, Vonsattel JP, Honig LS (2013). Early neuropsychological discriminants for Lewy body disease: an autopsy series. Journal of Neurology, Neurosurgery, and Psychiatry 84, 1326-1330